Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
University of Leeds has 6 pending office actions in Biotechnology & Pharmaceuticals. Each action is associated with a distinct examiner and a distinct art unit, so the portfolio has no repeated examiner or art-unit assignment in the available data.
JACOB, OOMMEN is the busiest examiner, with 1 pending action. Prosecution planning should therefore emphasize matter-specific technical records and consistent institutional review rather than a concentrated examiner strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACOB, OOMMEN | 1 | 79.2% | +17.3% |
| FURTADO, WINSTON RAHUL | 1 | 18.9% | +22.9% |
| LAFAVE, ELIZABETH ROSE | 1 | 64.4% | +43.2% |
| AEDER, SEAN E | 1 | 56.9% | +20.0% |
| BYRNES, DAVID R | 1 | 78.2% | +20.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19167566 | Device and System for Non-Invasively Determining a Concentration of an Analyte | JACOB, OOMMEN | — |
| 19116966 | METHOD AND APPARATUS FOR GENERATING VIRTUAL POPULATIONS OF ANATOMY | FURTADO, WINSTON RAHUL | — |
| 18278366 | IDENTIFICATION OF GENOMIC TARGETS | LAFAVE, ELIZABETH ROSE | — |
| 17765596 | PLANTS HAVING A MODIFIED LAZY PROTEIN | BYRNES, DAVID R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19167566 | Device and System for Non-Invasively Determining a Concentration of an Analyte | JACOB, OOMMEN | — |
| 19116966 | METHOD AND APPARATUS FOR GENERATING VIRTUAL POPULATIONS OF ANATOMY | FURTADO, WINSTON RAHUL | — |
| 18278366 | IDENTIFICATION OF GENOMIC TARGETS | LAFAVE, ELIZABETH ROSE | — |
| 18186765 | PREDICTION OF RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPIES USING EPIREGULIN AND AMPHIREGULIN | AEDER, SEAN E | — |
| 17765596 | PLANTS HAVING A MODIFIED LAZY PROTEIN | BYRNES, DAVID R | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| 3687 | 1 |
| 1684 | 1 |
| 1642 | 1 |
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19167566 | Device and System for Non-Invasively Determining a Concentration of an Analyte | JACOB, OOMMEN | 3797 | §103§112 | Non-Final OA | — | Pending | Sep 22, 2025 |
| 19116966 | METHOD AND APPARATUS FOR GENERATING VIRTUAL POPULATIONS OF ANATOMY | FURTADO, WINSTON RAHUL | 3687 | §101§103 | Non-Final OA | — | Pending | Mar 28, 2025 |
| 18278366 | IDENTIFICATION OF GENOMIC TARGETS | LAFAVE, ELIZABETH ROSE | 1684 | §103§112 | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18186765 | PREDICTION OF RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPIES USING EPIREGULIN AND AMPHIREGULIN | AEDER, SEAN E | 1642 | §103 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 17765596 | PLANTS HAVING A MODIFIED LAZY PROTEIN | BYRNES, DAVID R | 1662 | §102§112 | Final Rejection | — | Pending | Mar 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Leeds has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Oommen Jacob has the most, with 1 of University of Leeds's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
